Linda Tlili

Statistics

Publications

Citations

H-Index

Active since

2019

Affiliations

Institut de Chimie des Substances Naturelles(Current)

Université Paris-Saclay

CNR de la Résistance aux Antibiotiques

Assistance Publique – Hôpitaux de Paris

Bicêtre Hospital

Linda Tlili is an author at Institut de Chimie des Substances Naturelles specializing in pharmacology, class b metallo-beta-lactamases, and carbapenemase enzymes.

Publications per year

2019–2021

Publications

Unravelling ceftazidime/avibactam resistance of KPC-28, a KPC-2 variant lacking carbapenemase activity

Saoussen Oueslati, Bogdan I. Iorga, Linda Tlili et al. · Journal of Antimicrobial Chemotherapy · 2019 · 71 citations

Life Sciences, Molecular Biology, Pharmacology +17

Azetidinimines as a novel series of non-covalent broad-spectrum inhibitors of β-lactamases with submicromolar activities against carbapenemases KPC-2 (class A), NDM-1 (class B) and OXA-48 (class D)

Eugénie Romero, Saoussen Oueslati, Mohamed Benchekroun et al. · European Journal of Medicinal Chemistry · 2021 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

1–2 of 2